Integra LifeSciences Holdings (IART) — Cash Flow Reinvestment Rate
Integra LifeSciences Holdings (IART) has a Cash Flow Reinvestment Rate of 1.51x as of March 2026, reinvesting $14.85 Million (capex $14.85 Million ) from operating cash flow of $9.80 Million. Check IART operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Integra LifeSciences Holdings Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Integra LifeSciences Holdings across 26 annual periods. Explore investment intensity of Integra LifeSciences Holdings to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Integra LifeSciences Holdings (1999–2025)
Year-by-year capital reinvestment analysis for Integra LifeSciences Holdings. For live market cap and broader valuation context, see Integra LifeSciences Holdings market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.86x | $93.86 Million | $50.38 Million | $81.44 Million | ▼ -51.3% |
| 2024 | 3.83x | $495.23 Million | $129.38 Million | $104.42 Million | ▲ +232.6% |
| 2023 | 1.15x | $161.04 Million | $139.96 Million | $66.86 Million | ▲ +485.3% |
| 2022 | 0.20x | $51.99 Million | $264.47 Million | $47.09 Million | ▲ +27.5% |
| 2021 | 0.15x | $48.16 Million | $312.43 Million | $48.08 Million | ▼ -56.2% |
| 2020 | 0.35x | $71.73 Million | $203.83 Million | $63.89 Million | ▼ -40.5% |
| 2019 | 0.59x | $136.87 Million | $231.43 Million | $134.53 Million | ▲ +50.1% |
| 2018 | 0.39x | $78.65 Million | $199.68 Million | $77.74 Million | ▼ -26.0% |
| 2017 | 0.53x | $60.94 Million | $114.54 Million | $43.50 Million | ▼ -31.2% |
| 2016 | 0.77x | $89.95 Million | $116.41 Million | $47.33 Million | ▲ +45.0% |
| 2015 | 0.53x | $50.36 Million | $94.48 Million | $33.41 Million | ▼ -28.6% |
| 2014 | 0.75x | $59.35 Million | $79.46 Million | $42.40 Million | ▼ -16.9% |
| 2013 | 0.90x | $47.85 Million | $53.27 Million | $47.85 Million | ▼ -26.7% |
| 2012 | 1.23x | $72.00 Million | $58.72 Million | $69.03 Million | ▲ +232.9% |
| 2011 | 0.37x | $38.42 Million | $104.33 Million | $38.42 Million | ▲ +4.7% |
| 2010 | 0.35x | $37.14 Million | $105.57 Million | $37.14 Million | ▲ +82.8% |
| 2009 | 0.19x | $27.57 Million | $143.24 Million | $27.57 Million | ▲ +4.3% |
| 2008 | 0.18x | $13.40 Million | $72.59 Million | $13.40 Million | ▼ -61.5% |
| 2007 | 0.48x | $22.57 Million | $47.03 Million | $22.57 Million | ▲ +198.8% |
| 2006 | 0.16x | $11.52 Million | $71.70 Million | $11.52 Million | ▲ +13.4% |
| 2005 | 0.14x | $8.05 Million | $56.85 Million | $8.05 Million | ▼ -35.1% |
| 2004 | 0.22x | $8.51 Million | $38.98 Million | $8.51 Million | ▲ +97.8% |
| 2003 | 0.11x | $3.84 Million | $34.83 Million | $3.84 Million | ▲ +56.6% |
| 2002 | 0.07x | $2.25 Million | $31.98 Million | $2.25 Million | ▼ -61.3% |
| 2001 | 0.18x | $2.86 Million | $15.70 Million | $2.86 Million | ▼ -97.4% |
| 1999 | 6.92x | $17.30 Million | $2.50 Million | $17.30 Million | — |